Literature DB >> 17512902

Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells.

Hyun Joong Yoon1, Myoung E Moon, Haeng Soon Park, Suhn Young Im, Young Ho Kim.   

Abstract

The focus of this study was to clarify the relation between the nitric oxide (NO) production and cytokine expression including tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), and also investigated the effect of COS on LPS stimuli from RAW 264.7 cell. The lipopolysaccharide (LPS) of Gram-negative bacteria induces the expression of cytokines and potent inducers of inflammatory cytokines such as TNF-alpha and IL-6. In this experiment, upon stimulation with increasing concentrations of chitosan, the LPS-stimulated TNF-alpha and IL-6 secretion was significantly recovered within the incubation media of RAW 264.7 cells. Consistently, RT-PCR with mRNA and Western blot with anti-cytokine antiserum including TNF-alpha and IL-6 showed that the amount of TNF-alpha and IL-6 secretion in the incubation media recovered with the concentration of chitosan. The LPS-stimulated NO secretion was significantly recovered within the 6h and 12h incubation media of RAW 264.7 cells, too. The recovery effect of chitosan on IL-6 and NO secretion may be induced via the stimulus of TNF-alpha in RAW 264.7 cell. These results once again suggest that chitosan oligosaccharide may have the anti-inflammatory effect via the stimulus of TNF-alpha in the LPS-stimulated inflammation in RAW 264.7 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512902     DOI: 10.1016/j.bbrc.2007.05.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  Chitosan oligosaccharides suppress production of nitric oxide in lipopolysaccharide-induced N9 murine microglial cells in vitro.

Authors:  Peng Wei; Pan Ma; Qing-Song Xu; Qun-Hua Bai; Jian-Guo Gu; Hao Xi; Yu-Guang Du; Chao Yu
Journal:  Glycoconj J       Date:  2012-05-24       Impact factor: 2.916

2.  In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis.

Authors:  M Terčelj; S Stopinšek; A Ihan; B Salobir; S Simčič; B Wraber; R Rylander
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

3.  Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages.

Authors:  Yan-Fang Xian; Yu-Cui Li; Siu-Po Ip; Zhi-Xiu Lin; Xiao-Ping Lai; Zi-Ren Su
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

4.  Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases.

Authors:  Hong-tao Liu; Pei Huang; Pan Ma; Qi-shun Liu; Chao Yu; Yu-guang Du
Journal:  Acta Pharmacol Sin       Date:  2011-04       Impact factor: 6.150

5.  Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.

Authors:  Kenneth A Howard; Søren R Paludan; Mark A Behlke; Flemming Besenbacher; Bent Deleuran; Jørgen Kjems
Journal:  Mol Ther       Date:  2008-09-30       Impact factor: 11.454

6.  Endotoxins affect diverse biological activity of chitosans in matters of hemocompatibility and cytocompatibility.

Authors:  Andrea Nolte; Susanne Hossfeld; Marcell Post; Jan Niederlaender; Tobias Walker; Christian Schlensak; Hans Peter Wendel
Journal:  J Mater Sci Mater Med       Date:  2014-05-31       Impact factor: 3.896

7.  Ternary polymeric nanoparticles for oral siRNA delivery.

Authors:  Jing Zhang; Chunbai He; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

8.  Targeting Dysfunctional Vascular Endothelial Cells Using Immunoliposomes Under Flow Conditions.

Authors:  Mahsa Kheradmandi; Ian Ackers; Monica M Burdick; Ramiro Malgor; Amir M Farnoud
Journal:  Cell Mol Bioeng       Date:  2020-05-04       Impact factor: 2.321

Review 9.  The Expanded Role of Chitosan in Localized Antimicrobial Therapy.

Authors:  Lisa Myrseth Hemmingsen; Nataša Škalko-Basnet; May Wenche Jøraholmen
Journal:  Mar Drugs       Date:  2021-12-08       Impact factor: 5.118

10.  Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response.

Authors:  Yu Li; Hongtao Liu; Qing-Song Xu; Yu-Guang Du; Jian Xu
Journal:  Carbohydr Polym       Date:  2013-09-02       Impact factor: 9.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.